Photo from Akash Maniam/LinkedIn
May 23, 2024, 11:22
Akash Maniam: The world of managing HR+ breast cancer has become so amazingly complex in such a short space of time
Akash Maniam, Medical Oncologist at
“Phase II IO + PARPi + endocrine therapy combination data for advanced HR+ breast cancer – durvalumab + olaparib + fulvestrant.
The world of managing HR+ breast cancer has become so amazingly complex in such a short space of time.
Nearly impossible to keep up but I absolutely love it!”
Source: Akash Maniam/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 14:05
Nov 14, 2024, 13:49
Nov 14, 2024, 13:44
Nov 14, 2024, 13:37
Nov 14, 2024, 13:32
Nov 14, 2024, 13:29